YU104191A - Supstituisani benzimidazoli i postupak za njihovo dobijanje - Google Patents

Supstituisani benzimidazoli i postupak za njihovo dobijanje

Info

Publication number
YU104191A
YU104191A YU104191A YU104191A YU104191A YU 104191 A YU104191 A YU 104191A YU 104191 A YU104191 A YU 104191A YU 104191 A YU104191 A YU 104191A YU 104191 A YU104191 A YU 104191A
Authority
YU
Yugoslavia
Prior art keywords
carbon atoms
substituted benzimidazoles
procedure
obtaining
alkyl containing
Prior art date
Application number
YU104191A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
A.E. Braendstroem
P.L. Lindberg
G.E. Sinnden
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Publication of YU104191A publication Critical patent/YU104191A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
YU104191A 1990-06-20 1991-06-12 Supstituisani benzimidazoli i postupak za njihovo dobijanje YU104191A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002206A SE9002206D0 (sv) 1990-06-20 1990-06-20 New compounds

Publications (1)

Publication Number Publication Date
YU104191A true YU104191A (sh) 1994-01-20

Family

ID=20379831

Family Applications (1)

Application Number Title Priority Date Filing Date
YU104191A YU104191A (sh) 1990-06-20 1991-06-12 Supstituisani benzimidazoli i postupak za njihovo dobijanje

Country Status (27)

Country Link
EP (1) EP0535081A1 (enExample)
JP (1) JPH05507713A (enExample)
CN (1) CN1058212A (enExample)
AP (1) AP215A (enExample)
AU (1) AU649453B2 (enExample)
BG (1) BG97200A (enExample)
CA (1) CA2083714A1 (enExample)
CZ (1) CZ279772B6 (enExample)
FI (1) FI925766A0 (enExample)
HU (1) HUT62881A (enExample)
IE (1) IE912025A1 (enExample)
IL (1) IL98470A0 (enExample)
IS (1) IS3721A7 (enExample)
LT (2) LT3952B (enExample)
LV (1) LV10953A (enExample)
MA (1) MA22199A1 (enExample)
NO (1) NO924775L (enExample)
NZ (1) NZ238546A (enExample)
OA (1) OA09682A (enExample)
PT (1) PT98035A (enExample)
RO (1) RO110493B1 (enExample)
SE (1) SE9002206D0 (enExample)
TN (1) TNSN91049A1 (enExample)
TW (1) TW216418B (enExample)
WO (1) WO1991019711A1 (enExample)
YU (1) YU104191A (enExample)
ZA (2) ZA914296B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
CA2400953A1 (en) 2000-02-24 2001-08-30 Kopran Research Laboratories Limited Orally administrable acid stable anti-ulcer benzimidazole derivatives
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
DE60325709D1 (de) 2002-04-09 2009-02-26 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
KR20060092255A (ko) 2003-09-26 2006-08-22 알자 코포레이션 고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
TW200606163A (en) 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070015782A1 (en) 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
WO2007122686A1 (ja) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. ベンズイミダゾール化合物
ES2511792T3 (es) 2006-07-25 2014-10-23 Vecta Ltd. Composiciones y métodos para la inhibición de la secreción de ácido gástrico usando derivados de pequeños ácidos dicarboxílicos en combinación con IBP
US20110009624A9 (en) * 2006-10-13 2011-01-13 Masato Ueda Benzimidazole compounds having gastric acid secretion inhibitory action
BRPI0918492A2 (pt) 2008-09-09 2015-12-01 Astrazeneca Ab uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
AU2010263304A1 (en) 2009-06-25 2012-02-02 Astrazeneca Ab Method for treating a patient at risk for developing an NSAID-associated ulcer
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
US20120294937A1 (en) 2009-12-29 2012-11-22 Novartis Ag New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
EP2797600A4 (en) 2011-12-28 2015-09-16 Pozen Inc IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID
KR102409502B1 (ko) 2016-09-14 2022-06-16 위펑 제인 쳉 D-아미노산 옥시다제 (daao) 저해제로서 신규한 치환된 벤즈이미다졸 유도체

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (enExample) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
SE8300736D0 (sv) 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US4738975A (en) 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
NZ222495A (en) 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
MY103790A (en) * 1987-10-30 1993-09-30 Ab Hassle Novel compound for the treatment of several bone affecting diseases
JPH03501609A (ja) * 1987-12-11 1991-04-11 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング 新規ベンゾイミダゾール誘導体
JPH03504497A (ja) * 1988-05-25 1991-10-03 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング 新規フルオルアルコキシ化合物

Also Published As

Publication number Publication date
AU649453B2 (en) 1994-05-26
LV10953A (lv) 1995-12-20
CN1058212A (zh) 1992-01-29
IE912025A1 (en) 1992-01-01
LT3952B (en) 1996-05-27
NO924775D0 (no) 1992-12-10
IL98470A0 (en) 1992-07-15
LTIP1713A (en) 1995-08-25
HU9204033D0 (en) 1993-03-29
CS189491A3 (en) 1992-04-15
SE9002206D0 (sv) 1990-06-20
PT98035A (pt) 1992-03-31
NZ238546A (en) 1994-03-25
FI925766A7 (fi) 1992-12-18
LT3977B (en) 1996-06-25
AP9100285A0 (en) 1991-07-31
LTIP1712A (en) 1995-08-25
WO1991019711A1 (en) 1991-12-26
CA2083714A1 (en) 1991-12-21
FI925766A0 (fi) 1992-12-18
NO924775L (no) 1992-12-10
RO110493B1 (ro) 1996-01-30
JPH05507713A (ja) 1993-11-04
ZA914296B (en) 1992-03-25
ZA914297B (en) 1992-03-25
AP215A (en) 1992-09-02
BG97200A (bg) 1993-12-24
EP0535081A1 (en) 1993-04-07
AU8009791A (en) 1992-01-07
TW216418B (enExample) 1993-11-21
IS3721A7 (is) 1991-12-21
OA09682A (en) 1993-05-15
MA22199A1 (fr) 1992-04-01
TNSN91049A1 (fr) 1992-10-25
HUT62881A (en) 1993-06-28
CZ279772B6 (cs) 1995-06-14

Similar Documents

Publication Publication Date Title
YU104191A (sh) Supstituisani benzimidazoli i postupak za njihovo dobijanje
TW234116B (en) 2-Cyano-3-hydroxy-enamides and their preparation process
YU36998A (sh) Derivati supstituisane 4-hidroksi-fenilalkanske kiseline sa dejstvom agonista na ppar gama
YU64092A (sh) Fluoralkoksibenzamino derivati heterocikličnih jedinjenja koja sadrže azot
YU24792A (sh) Novi amidi ugljene kiseline
ATE126517T1 (de) Verwendung von bis(3,4- dialkylbenzyliden)sorbitolacetale und diese enthaltende zusammensetzungen.
US4161584A (en) Cycloamides of nitriloprostacyclins
YU47116B (sh) Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata
YU30492A (sh) Derivati piperidina i postupci za njihovo dobijanje
EA199800987A1 (ru) Бензоксазиноновые антагонисты рецептора допамина d4
FI834730A0 (fi) 1-karboxialkanoylperhydro-indol-2-karboxylsyror och deras derivat
DE69319925D1 (de) Indol-piperazin-derivate als selektive liganden der 5ht1d und 5ht1b receptoren verwendbar als arzneimittel
US4129726A (en) 9-Deoxy-9-methylene-PGF1 -piperizinylamides
ES395057A1 (es) Procedimiento para la obtencion de acidos bis-(triazinila- mino) - estilbensulfonicos.
ES2070623T3 (es) Oxisulfonilureas inhibidoras de acat.
ES485153A1 (es) Procedimiento para la obtencion de 6-arilpiridazin-3-onas
YU44592A (sh) Derivati 4-aril-3-(heteroarilkarbamido) hinolina
FI923492A0 (fi) Indolderivat, deras framstaellning och anvaendning.
ES8407059A1 (es) Procedimiento para la preparacion de un nuevo derivado del pirrolo ortocondensado
ATE162191T1 (de) Azanoradamantane
ATE215083T1 (de) Bicyclische carboxamide als 5-ht1a rezeptoren liganden
ES467861A1 (es) Procedimiento de preparacion de espiro-oxazolidinas esteroi-des y sus esteroisomeros.
ES442441A1 (es) Procedimiento para preparar derivados de oxatinino (1,4) (2,3-c) pirrol.
ES8707204A1 (es) Procedimiento para preparar diazepinoindoles
YU150690A (sh) Benzotiazinski derivati i postupak za njihovo dobijanje